2-Acetylaminofluorene and N-hydroxy-2-acetylaminofluorene inhibition of incorporation of orotic acid-5-3H into nuclear ribosomal and heterogeneous RNA in normal and regenerating liver.
D000818:Animals; D002273:Carcinogens / Q000494:pharmacology*; D002466:Cell Nucleolus / Q000378:metabolism; D002467:Cell Nucleus / Q000378:metabolism*; D012321:DNA-Directed RNA Polymerases / Q000037:antagonists & inhibitors; D004305:Dose-Response Relationship, Drug; D005260:Female; D005449:Fluorenes / Q000494:pharmacology*; D006498:Hepatectomy; D008115:Liver Regeneration; D008297:Male; D009963:Orotic Acid / Q000378:metabolism*; D011132:Polyribosomes / Q000378:metabolism; D012313:RNA / Q000096:biosynthesis*; D012333:RNA, Messenger / Q000378:metabolism; D012335:RNA, Ribosomal / Q000096:biosynthesis*; D051381:Rats; D012737:Sex Factors; D014316:Tritium; D014500:Uracil Nucleotides / Q000096:biosynthesis
D002273:Carcinogens; D005449:Fluorenes; D012333:RNA, Messenger; D012335:RNA, Ribosomal; D014500:Uracil Nucleotides; D014316:Tritium; D009963:Orotic Acid; D012313:RNA; D012321:DNA-Directed RNA Polymerases